Cargando…
Benefit of 5 years of enzyme replacement therapy in advanced late onset Pompe. A case report of misdiagnosis for three decades with acute respiratory failure at presentation
We report on a 57 year old female patient who presented in acute respiratory failure with severe generalized weakness. She was previously misdiagnosed for over three decades as polymyositis. She was treated with enzyme replacement therapy (ERT) for over five years, after being diagnosed with late on...
Autores principales: | Maharaj, Mandat, Skidmore, David L., Croul, Sidney E., Brake, David J., Lochmuller, Hanns |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9421430/ https://www.ncbi.nlm.nih.gov/pubmed/36046397 http://dx.doi.org/10.1016/j.ymgmr.2022.100896 |
Ejemplares similares
-
Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014) -
The impact of interrupting enzyme replacement therapy in late-onset Pompe disease
por: Wenninger, Stephan, et al.
Publicado: (2021) -
Standardized nursing management of enzyme replacement therapy for late-onset Pompe disease
por: Tang, Shan, et al.
Publicado: (2021) -
Muscle Proteomic Profile before and after Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Moriggi, Manuela, et al.
Publicado: (2021) -
A Systematic Review and Meta-Analysis of Enzyme Replacement Therapy in Late-Onset Pompe Disease
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2021)